Heartland Group Holdings (HGH.AX) Earnings Analysis

Heartland Group Holdings (HGH.AX) next reports earnings on 2026-08-20, consensus EPS 0.00594 AUD. Last quarter (2026-02-25) it beat with EPS 0.04226 AUD vs 0.03925 AUD est (+7.7%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 14.06.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does HGH.AX next report earnings?

Next earnings date2026-08-20
Consensus EPS estimate0.00594 AUD
Revenue estimate0.28B

HGH.AX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-250.04226 AUD0.03925 AUD+7.7%Beat
2025-09-010.0335 AUDn/an/an/a
2024-09-300.0421 AUDn/an/an/a

Beat rate: 1/1 (100%) over reported quarters with consensus data.

HGH.AX valuation and analyst view

Trailing P/E14.06
Trailing EPS0.08926 AUD
Price / book0.91
Dividend yield4.93%
Market cap0.95B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Heartland Group Holdings (HGH.AX)'s next earnings date?

Heartland Group Holdings is next scheduled to report on 2026-08-20, with a consensus EPS estimate of 0.00594 AUD and revenue estimate of 0.28B.

Did HGH.AX beat earnings last quarter?

In its 2026-02-25 report, HGH.AX posted EPS of 0.04226 AUD versus a 0.03925 AUD estimate — a beat of 7.7%.

What is HGH.AX's earnings track record?

Over the last 1 reported quarters with consensus data, HGH.AX beat estimates 1 times (100%).

What is HGH.AX's current P/E ratio and EPS?

HGH.AX trades at a trailing P/E of 14.06 on trailing EPS of 0.08926134366227997 AUD.

What do analysts rate HGH.AX?

HGH.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.